Pushing hyperthermia forward:
hi-tech nanoparticles for a non invasive oncology approach
Nanotechnologies today make it possible to realize an idea that is over 100 years old: treating cancer patients with localized and precision hyperthermia. Nanoradox exploits the physical properties of nanoparticles to produce localized heat capable of destroying tumor cells.
Nanoradox is a Class III Medical Device (accordingly to the European Regulation) which is made up of a solution of iron oxide nanoparticles to be injected into the tumor mass and a machine that emits radio frequencies. As a result of the radio frequencies, the nanoparticles overheat and cause apoptosis of tumor cells.
The product is unique and innovative due to its high effectiveness and very low impact on the patient.
Looking ahead, Nanoradox can be used in combination with the most innovative treatments since it does not interfere with any drug: its action is purely physical (hyperthermia). In addition, the treatment is economical and requires neither particular skills nor spaces/equipment that are difficult or expensive to find.